The c.395A>T variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of glutamic acid to valine at codon 132 (p.(Glu132Val)) of NM_000545.8. This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.93, which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant resides in an amino acid within the HNF1α DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with a clinical history highly specific for HNF1A-MODY (MODY probability calculator result nearly 50%, negative genetic testing for HNF4A, negative antibodies, and 3 generation family history of diabetes) (PP4; internal lab contributors). Another missense variant, c.394G>A p.Glu132Lys, has been classified as pathogenic by the ClinGen MDEP, and p.Glu132Asp has a greater Grantham distance. In summary, c.395A>T meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.1.0, approved 8/11/2023): PM1, PM5, PP3, PP4, PM2_Supporting.